AliveCor, developer of the Kardia™ Mobile (formerly known as the AliveCor Heart Monitor) FDA-cleared electrocardiogram (EKG) technology for mobile devices, has announced the introduction of the first medical-grade EKG band for the Apple Watch, Kardia™ Band.
- The Kardia™ Band is pending 510k clearance and is not yet available for sale in the U.S.
- The Kardia™ Band will be the first medical grade electrocardiogram (EKG) band for the Apple Watch and a breakthrough in proactive heart health.
- The Kardia ™Band will be able to provide instant EKG analysis. With a touch of the Watch band, the user will know instantly if the heart rhythm is normal or if atrial fibrillation (AF) is detected.
- The Kardia™ Band and related app will be able to capture heart activity data and relay it to your the user’s healthcare provider to inform their diagnosis and treatment plan.
- The Kardia™ Band user can use voice memos to keep track of palpitations, shortness of breath, dietary habits and exercise patterns.
- The Kardia™ Band Integrates with Health app and Google Fit for personal heart health insights.
Great to see wearable health technology growing in usability and accessability.
For more information see:
AliveCor unveils Kardia Band, a medical-grade EKG band for Apple Watch
Cardiogram, a healthcare startup, was recently awarded $2M from several angel investors to develop gathering the sensor data from the Apple Watch to aid in detecting atrial fibrillation. The Cardiogram app takes the heart rate data stored in the Health app and organizes it into graphs both real-time and short-term graphs, such as the heart rate over the course of a stressful meeting, and long-term trend graphs, like resting heart rate over time.
Cardiogram has been working with UCSF since March to collect user data in a study called mRhythm and use it to develop an app for detecting atrial fibrillation based on on Apple Watch data. The mRhythm study has gathered more than 10 billion sensor measurements from more than 100,000 contributors over the past six months. The Cardiogram app readings from patients with known ECG confirmed atrial fibrillation are being used to teach the software the heartbeat patterns that correlate with the arrhythmia. Their algorithm can reportedly correctly detect 9 out of 10 cases of atrial fibrillation. However, to be of clinical use, the accuracy must be higher. mRhythm study participants with an AliveCor Kardia device are also being asked to link their Kardia data.
For more information about Cardiogram see:
For more information on the mRhythm Study see:
Health insurance provider Aetna has announced that it will subsidize the cost of an Apple Watch for some of its customers. Employers that offer Aetna health insurance policies will decide if they want to offer the Apple Watch program to their employees. The program offers monthly payroll deductions to make covering the remaining cost easier. In addition, Aetna will provide Apple Watch at no cost to its own nearly 50,000 employees that participate in the company’s wellness reimbursement program, to encourage them to live more productive, healthy lives.
Aetna reports that they are also planning several iOS-exclusive health initiatives, starting with deeply integrated health apps for iPhone, iPad and Apple Watch that will significantly improve the ability of consumers to manage their health and increase healthy outcomes.
Aetna’s iOS-exclusive health apps should be available in early 2017 and include:
will aim to simplify the healthcare process through a number of features, including:
- A care management and wellness app, to help guide consumers through health events like a new diagnosis or prescription medication with user-driven support from nurses and people with similar conditions.
- A medication adherence app, to help consumers remember to take their medications, easily order refills and connect with their doctor if they need a different treatment through their Apple Watch or iPhone.
- Integration with Apple Wallet, allowing consumers to check their deductible and pay a bill.
- Personalized health plan on-boarding, information, messaging and decision support to help Aetna members understand and make the most of their benefits.
For more information see:
Polaris Health Directions has partnered with the MD Anderson Cancer Center at Cooper to conduct an integrated medical-behavioral health pilot project, using the Apple Watch to capture behavioral data that could affect the courses and outcomes of treatment for breast cancer patients.
Polaris provides the following overview of the pilot project:
- Polaris will underwrite the devices (Apple Watch™ Sport 38mm models with pink straps) and development of the app, being responsible for configuration, scientific content design, deployment, monitoring, and support for the wearables platform.
- MD Anderson Cooper will select a group of breast cancer patients in active treatment, provide personnel and support, and will consult on product design and usability within the health network, as well as within patients’ non-institutional settings. Their health professionals will review the data captured and provide patient support based on the analysis of the data.
- The project will undergo review and is subject to approval by the Cooper Institutional Review Board. With the support of the IRB, MD Anderson Cooper and Polaris could then jointly publish project findings, at intervals to be determined.
The project will focus on how patients cope with anxiety and depression during two stages of cancer: immediately after they’ve been diagnosed, and after treatment is completed. Researchers at MD Anderson Cooper expect that using the Apple Watch will help increase engagement and collect data that enables them to refine patient treatment plans.
For more information: